XPhyto Therapeutics Corp. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was CAD 0.116931 million compared to CAD 0.084622 million a year ago. Net loss was CAD 2.6 million compared to CAD 6.8 million a year ago. Basic loss per share from continuing operations was CAD 0.04 compared to CAD 0.11 a year ago. For the nine months, sales was CAD 0.128314 million compared to CAD 0.268324 million a year ago. Net loss was CAD 12.13 million compared to CAD 14.08 million a year ago. Basic loss per share from continuing operations was CAD 0.18 compared to CAD 0.25 a year ago.